SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A AMENDMENT TO APPLICATION OR REPORT Pursuant to Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 BIOMET, INC. (Exact name of registrant as specified in its charter) Indiana 0-12515 35-1418342 (State or other jurisdiction (Commission File Number) (I.R.S. Employer ofincorporation Identification No.) or organization) Airport Industrial Park, P.O. Box 587, Warsaw, Indiana 46581-0587 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (219) 267-6639 AMENDMENT NO. 1 The undersigned registrant hereby amends its response to Item 7, Financial Statements and Exhibits, of its Current Report on Form 8-K, dated February 17, 1998, as set forth below: Item 7. Financial Statements and Exhibits. (a-b) No financial statements or pro forma financial information are required to be filed as part of this report. (c) See Index to Exhibits. The schedules and exhibits to the Joint Venture Agreement filed as an Exhibit hereto are not included in reliance upon Item 601(b)(2) of Regulation S-K. The undersigned registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to the Commission upon request. Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this amendment to be signed on its behalf by the undersigned, thereunto duly authorized. BIOMET, INC. By: /s/ Gregory D. Hartman Gregory D. Hartman Vice President, Finance Dated: April 14, 1998